Cargando…
Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c‐MYC axis in breast cancer
Breast cancer is the second leading death cause of cancer death for all women. Previous study suggested that Protein Kinase D3 (PRKD3) was involved in breast cancer progression. In addition, the protein level of PRKD3 in triple‐negative breast adenocarcinoma was higher than that in normal breast tis...
Autores principales: | Liu, Yan, Song, Hang, Yu, Shiyi, Huang, Kuo‐Hsiang, Ma, Xinxing, Zhou, Yehui, Yu, Shuang, Zhang, Jingzhong, Chen, Liming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011155/ https://www.ncbi.nlm.nih.gov/pubmed/31944568 http://dx.doi.org/10.1111/jcmm.14772 |
Ejemplares similares
-
Inhibition Lysosomal Degradation of Clusterin by Protein Kinase D3 Promotes Triple‐Negative Breast Cancer Tumor Growth
por: Liu, Yan, et al.
Publicado: (2021) -
The oncogenic role of protein kinase D3 in cancer
por: Liu, Yan, et al.
Publicado: (2021) -
Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer‐related pathways in breast cancer
por: Liu, Yan, et al.
Publicado: (2019) -
ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis
por: Chen, Junru, et al.
Publicado: (2020) -
Targeting epidermal growth factor‐overexpressing triple‐negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor
por: Liu, Yan, et al.
Publicado: (2020)